Mainz Biomed Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40%.

Top 22 shareholders own 22.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.65%	KfW, Asset Management Arm	1,237,501	€222.6k	0%	no data
5.15%	Moritz Eidens	1,126,348	€202.6k	0%	no data
3.44%	Guido Baechler	752,357	€135.3k	0%	no data
3.28%	Hans Hekland	716,873	€129.0k	0%	no data
1.65%	Philipp Freese	361,972	€65.1k	0%	no data
0.97%	William Caragol	212,677	€38.3k	0%	no data
0.53%	Darin Leigh	115,417	€20.8k	0%	no data
0.4%	Heinrich Dreismann	88,000	€15.8k	0%	no data
0.16%	Nicole Holden	35,000	€6.3k	0%	no data
0.16%	Gregory Tibbitts	35,000	€6.3k	0%	no data
0.16%	Alberto Libanori	35,000	€6.3k	0%	no data
0.14%	Northern Trust Global Investments	29,934	€5.4k	0%	no data
0.11%	Vontobel Asset Management, Inc.	25,000	€4.5k	0%	no data
0.069%	Geode Capital Management, LLC	15,189	€2.7k	0%	no data
0.054%	Frank Krieg-Schneider	11,771	€2.1k	0%	no data
0.052%	XTX Holdings Limited, Asset Management Arm	11,358	€2.0k	-60.5%	no data
0.05%	Greenwich Investment Management, Inc.	10,859	€2.0k	-9.39%	no data
0.046%	Wealth Quarterback LLC	10,000	€1.8k	0%	no data
0.031%	Christopher Von Torne	6,771	€1.2k	0%	no data
0.0031%	Citigroup Inc.,Banking and Securities Investments	673	€120.9	0%	no data
0.00091%	Morgan Stanley, Investment Banking and Brokerage Investments	200	€35.8	-98.1%	no data
0.00046%	Bank of America Corporation, Asset Management Arm	100	€18.1	0%	no data